Patch vs. pill: new ozanimod skin patch tested in healthy volunteers
NCT ID NCT06528665
First seen Feb 27, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This study tested whether a skin patch (transdermal delivery system) can deliver the drug ozanimod as well as the oral capsule (Zeposia) in 24 healthy adults. Participants either took one capsule or wore a patch for 7 days. Researchers measured drug levels in the blood and checked for skin reactions. The goal was to find a better way to give this medicine for conditions like multiple sclerosis and ulcerative colitis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Ampang
Ampang, Selangor, 68000, Malaysia
Conditions
Explore the condition pages connected to this study.